Clinical cases of vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA vasculitis) induced by COVID-19
- 3 July 2024
- journal article
- research article
- Published by ECO-Vector LLC in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 16 (2) , 121-133
Abstract
COVID-19 is similar to immunoinflammatory rheumatic diseases in clinical manifestations, immune responses and pathogenetic mechanisms. Specific autoantibodies as markers of autoimmune diseases can be detected in patients with coronavirus infection. Most often, after COVID-19, antinuclear antibodies, antibodies to phospholipids, to cardiolipin, to β2-glycoprotein, to cytoplasmic antigens SS-A and SS/B, and cyclic citrulline-containing peptide are detected. In moderate and severe cases of COVID-19 infection with pulmonary-renal syndrome, cytokine storm, antineutrophil cytoplasmic antibodies, antibodies to myeloperoxidase and to proteinase 3 have become more frequent, which can trigger neutrophil NETosis with the formation of extracellular neutrophil traps — networks and induce the development of autoimmune processes and the appearance of de novo immunoinflammatory rheumatic diseases: arthritis , systemic lupus erythematosus, vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA vasculitis). Our study presents 4 clinical cases of patients with ANCA vasculitis with a history of recent coronavirus infection, chronologically verified. The average time after COVID-19 and the onset of ANCA vasculitis was about 3 months; damage to the upper respiratory tract, lower respiratory tract, skin and renal syndromes were observed. The severity of ANCA vasculitis did not depend on the severity of coronavirus infection: a mild course of COVID-19 infection did not exclude a severe course of ANCA vasculitis. It is recommended that all patients during and after coronavirus infection with post-COVID syndrome in the presence of damage to the ENT organs, kidneys, and skin are screened the presence of antineutrophil cytoplasmic antibodies to exclude the onset of ANCA vasculitis.Keywords
This publication has 46 references indexed in Scilit:
- COVID‐19: A trigger of autoimmune diseasesCell Biology International, 2023
- A case of left foot drop as initial symptom of granulomatosis with polyangiitis: Triggered by COVID‐19 disease?Clinical Case Reports, 2022
- A CASE OF MICROSCOPIC POLYANGIITIS (MPA) FOLLOWING SARS-COV-2 INFECTIONChest, 2022
- Overview of infections as an etiologic factor and complication in patients with vasculitidesRheumatology International, 2022
- Rheumatological complications of Covid 19Autoimmunity Reviews, 2021
- ANCA-associated vasculitis after COVID-19Rheumatology International, 2021
- COVID-19-associated vasculitis and vasculopathyJournal of Thrombosis and Thrombolysis, 2020
- Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID‐19 SeverityArthritis & Rheumatology, 2020
- Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?Autoimmunity Reviews, 2020
- Review: Viral infections and mechanisms of thrombosis and bleedingJournal of Medical Virology, 2012